Financial statements Apharm
Balance sheet of Apharm
Company age:
Age:
8 y. 5 m. 21 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of APHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 247 740,01 | 386 472,72 | 0,00 | 270 257,82 | 472 066,30 | 511 084,42 |
| A. Fixed assets | 224 000,00 | 364 750,00 | 0,00 | 265 000,00 | 234 951,67 | 152 091,67 |
| B. Current assets | 23 740,01 | 21 722,72 | 0,00 | 5 257,82 | 237 114,63 | 358 992,75 |
| C. Share capital contributions (basic funds) | - | 0,00 | - | - | - | - |
| D. Own shares (stocks) | - | 0,00 | - | - | - | - |
| Total liabilities | 247 740,01 | 386 472,72 | 0,00 | 270 257,82 | 472 066,30 | 511 084,42 |
| A. Equity | -59 341,60 | -118 667,21 | 0,00 | -85 835,66 | -10 281,79 | 156 731,62 |
| B. Liabilities and provisions for liabilities | 307 081,61 | 505 139,93 | 0,00 | 356 093,48 | 482 348,09 | 354 352,80 |
| I. Long-term liabilities | 0,00 | - | - | - | - | - |
| II. Short-term liabilities | 307 081,61 | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.